Vasohibin-2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor-2 and growth/differentiation factor-15 expression

Molecular Medicine Reports

Volumn 10, Issue 2, 2014, Pages 663-669

  Tu, Min ^a   Liu, Xian ^a   Han, Bei ^a   Ge, Qianqian ^a   Li, Zhanjun ^a   Lu, Zipeng ^a   Wei, Jishu ^a   Song, Guoxin ^a   Cai, Baobao ^a   Lv, Nan ^a   Jiang, Kuirong ^a   Wang, Shui ^a   Miao, Yi ^a   Gao, Wentao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Growth factor; Proliferation; Vasohibin 2

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR 2; GROWTH DIFFERENTIATION FACTOR 15; KI 67 ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 6; UNCLASSIFIED DRUG; VASOHIBIN 2; ANGIOGENIC PROTEIN; SIGNAL PEPTIDE; SMALL INTERFERING RNA; VASH2 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRDU ASSAY; BREAST CANCER CELL LINE; CARCINOGENESIS; CELL PROLIFERATION; CYTOPLASM; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MAJOR CLINICAL STUDY; MCF 7 CELL LINE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BREAST TUMOR; GENETICS; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PROTEIN MICROARRAY; RNA INTERFERENCE; XENOGRAFT;

ADULT; ANGIOGENIC PROTEINS; ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84903276894     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2317     Document Type: Article

References (24)

1. Sato Y: The vasohibin family: a novel family for angiogenesis regulation. J Biochem 153: 5-11, 2013.
2. Shibuya T, Watanabe K, Yamashita H, Shimizu K, Miyashita H, Abe M, Moriya T, Ohta H, Sonoda H, Shimosegawa T, Tabayashi K and Sato Y: Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Arterioscler Thromb Vasc Biol 26: 1051-1057, 2006. (Pubitemid 43732111)
3. Kimura H, Miyashita H, Suzuki Y, Kobayashi M, Watanabe K, Sonoda H, Ohta H, Fujiwara T, Shimosegawa T and Sato Y: Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood 113: 4810-4818, 2009.
4. Xue X, Gao W, Sun B, Xu Y, et al: Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. Oncogene 32: 1724-1734, 2013.
5. Takahashi Y, Koyanagi T, Suzuki Y, Saga Y, Kanomata N, Moriya T, Suzuki M and Sato Y: Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis. Mol Cancer Res 10: 1135-1146, 2012.
6. Koyanagi T, Suzuki Y, Saga Y, Machida S, Takei Y, Fujiwara H, Suzuki M and Sato Y: In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer. Cancer Sci 104: 1705-1710, 2013.
7. Sun J, Tu M, Han B, Xue X, et al: Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization. Int J Oncol 43: 255-261, 2013.
8. Beresford MJ, Wilson GD and Makris A: Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res 8: 216, 2006.
9. Lopez F, Belloc F, Lacombe F, Dumain P, Reiffers J, Bernard P and Boisseau MR: Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry 12: 42-49, 1991.
10. Verheijen R, Kuijpers HJ, Schlingemann RO, Boehmer AL, van Driel R, Brakenhoff GJ and Ramaekers FC: Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase. J Cell Sci 92: 123-130, 1989.
11. Heidebrecht HJ, Buck F, Haas K, Wacker HH and Parwaresch R: Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the 'Ki-67' proteins. Cell Prolif 29: 413-425, 1996. (Pubitemid 26345569)
12. Allred DC, Mohsin SK and Fuqua SA: Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 8: 47-61, 2001. (Pubitemid 32520253)
13. Rudas M, Neumayer R, Gnant MF, Mittelböck M, Jakesz R and Reiner A: p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Eur J Cancer 33: 39-44, 1997. (Pubitemid 27099565)
14. Shoker BS, Jarvis C, Davies MP, Iqbal M, Sibson DR and Sloane JP: Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. Br J Cancer 84: 1064-1069, 2001. (Pubitemid 32448503)
15. Kontzoglou K, Palla V, Karaolanis G, Karaiskos I, Alexiou I, Pateras I, Konstantoudakis K and Stamatakos M: Correlation between Ki67 and breast cancer prognosis. Oncology 84: 219-225, 2013.
16. Sporn MB and Todaro GJ: Autocrine secretion and malignant transformation of cells. N Engl J Med 303: 878-880, 1980.
17. Witsch E, Sela M and Yarden Y: Roles for growth factors in cancer progression. Physiology (Bethesda) 25: 85-101, 2010.
18. Chandler LA, Sosnowski BA, Greenlees L, Aukerman SL, Baird A and Pierce GF: Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines. Int J Cancer 81: 451-458, 1999. (Pubitemid 29165205)
19. Yin T, Cho SJ and Chen X: RNPC1, an RNA-binding protein and a p53 target, regulates macrophage inhibitory cytokine-1 (MIC-1) expression through mRNA stability. J Biol Chem 288: 23680-23686, 2013.
20. Chitnis MM, Yuen JS, Protheroe AS, Pollak M and Macaulay VM: The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res 14: 6364-6370, 2008.
21. Bach LA, Fu P and Yang Z: Insulin-like growth factor-binding protein-6 and cancer. Clin Sci (Lond) 124: 215-229, 2013.
22. Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA and Yee D: Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 88: 601-606, 1996. (Pubitemid 26137582)
23. Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng Cn, Lee AV and Yee D: Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Cancer Res 3: 103-109, 1997. (Pubitemid 27079451)
24. Natsuizaka M, Kinugasa H, Kagawa S, Whelan KA, et al: IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment. Am J Cancer Res 4: 29-41, 2014.